Biopharmaceuticals Market - Global Outlook and Forecast 2021-2027
Report Code: KNJ759567 No. of Pages: 92 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
The Biopharmaceuticals market report provides the overall market analysis of the industry. This market report presents the current snapshot of the Biopharmaceuticals market to understand the market's key features. The content of the report highlights the important market criteria that help to develop the market further. The report provides the value and the volume of the Biopharmaceuticals at global, regional, and company levels. The historical market value for the year 2021 along with the market value for the upcoming year 2027 has been presented in the market report. Along with that, the report also provides information on subjects such as Export, import, production, and production capacity of the Biopharmaceuticals market.This report contains market size and forecasts of Biopharmaceuticals in Global, including the following market information: Global Biopharmaceuticals Market Revenue, 2016-2021, 2022-2027, ($ millions) Global top five companies in 2020 (%) The global Biopharmaceuticals market was valued at 84710 million in 2020 and is projected to reach US$ 101010 million by 2027, at a CAGR of 4.5% during the forecast period. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biopharmaceuticals companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Biopharmaceuticals Market, By Type, 2016-2021, 2022-2027 ($ millions) Global Biopharmaceuticals Market Segment Percentages, By Type, 2020 (%) Monoclonal Antibodies Interferon Colony-Stimulating Factor Erythropoietin Insulin Vaccines Growth Hormones Others China Biopharmaceuticals Market, By Application, 2016-2021, 2022-2027 ($ millions) China Biopharmaceuticals Market Segment Percentages, By Application, 2020 (%) Tumor Diabetes Cardiovascular Hemophilia Others Global Biopharmaceuticals Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) Global Biopharmaceuticals Market Segment Percentages, By Region and Country, 2020 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Total Biopharmaceuticals Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions) Total Biopharmaceuticals Market Competitors Revenues Share in Global, by Players 2020 (%) Further, the report presents profiles of competitors in the market, including the following: Roche Amgen AbbVie Sanofi-Aventis Johnson & Johnson Pfizer Novo Nordisk Eli Lilly Novartis Merck
1 Introduction to Research & Analysis Reports
1.1 Biopharmaceuticals Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biopharmaceuticals Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biopharmaceuticals Overall Market Size
2.1 Global Biopharmaceuticals Market Size: 2021 VS 2027
2.2 Global Biopharmaceuticals Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biopharmaceuticals Players in Global Market
3.2 Top Global Biopharmaceuticals Companies Ranked by Revenue
3.3 Global Biopharmaceuticals Revenue by Companies
3.4 Top 3 and Top 5 Biopharmaceuticals Companies in Global Market, by Revenue in 2020
3.5 Global Companies Biopharmaceuticals Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biopharmaceuticals Players in Global Market
3.6.1 List of Global Tier 1 Biopharmaceuticals Companies
3.6.2 List of Global Tier 2 and Tier 3 Biopharmaceuticals Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Biopharmaceuticals Market Size Markets, 2021 & 2027
4.1.2 Monoclonal Antibodies
4.1.3 Interferon
4.1.4 Colony-Stimulating Factor
4.1.5 Erythropoietin
4.1.6 Insulin
4.1.7 Vaccines
4.1.8 Growth Hormones
4.1.9 Others
4.2 By Type - Global Biopharmaceuticals Revenue & Forecasts
4.2.1 By Type - Global Biopharmaceuticals Revenue, 2016-2021
4.2.2 By Type - Global Biopharmaceuticals Revenue, 2022-2027
4.2.3 By Type - Global Biopharmaceuticals Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biopharmaceuticals Market Size, 2021 & 2027
5.1.2 Tumor
5.1.3 Diabetes
5.1.4 Cardiovascular
5.1.5 Hemophilia
5.1.6 Others
5.2 By Application - Global Biopharmaceuticals Revenue & Forecasts
5.2.1 By Application - Global Biopharmaceuticals Revenue, 2016-2021
5.2.2 By Application - Global Biopharmaceuticals Revenue, 2022-2027
5.2.3 By Application - Global Biopharmaceuticals Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Biopharmaceuticals Market Size, 2021 & 2027
6.2 By Region - Global Biopharmaceuticals Revenue & Forecasts
6.2.1 By Region - Global Biopharmaceuticals Revenue, 2016-2021
6.2.2 By Region - Global Biopharmaceuticals Revenue, 2022-2027
6.2.3 By Region - Global Biopharmaceuticals Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Biopharmaceuticals Revenue, 2016-2027
6.3.2 US Biopharmaceuticals Market Size, 2016-2027
6.3.3 Canada Biopharmaceuticals Market Size, 2016-2027
6.3.4 Mexico Biopharmaceuticals Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Biopharmaceuticals Revenue, 2016-2027
6.4.2 Germany Biopharmaceuticals Market Size, 2016-2027
6.4.3 France Biopharmaceuticals Market Size, 2016-2027
6.4.4 U.K. Biopharmaceuticals Market Size, 2016-2027
6.4.5 Italy Biopharmaceuticals Market Size, 2016-2027
6.4.6 Russia Biopharmaceuticals Market Size, 2016-2027
6.4.7 Nordic Countries Biopharmaceuticals Market Size, 2016-2027
6.4.8 Benelux Biopharmaceuticals Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Biopharmaceuticals Revenue, 2016-2027
6.5.2 China Biopharmaceuticals Market Size, 2016-2027
6.5.3 Japan Biopharmaceuticals Market Size, 2016-2027
6.5.4 South Korea Biopharmaceuticals Market Size, 2016-2027
6.5.5 Southeast Asia Biopharmaceuticals Market Size, 2016-2027
6.5.6 India Biopharmaceuticals Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Biopharmaceuticals Revenue, 2016-2027
6.6.2 Brazil Biopharmaceuticals Market Size, 2016-2027
6.6.3 Argentina Biopharmaceuticals Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Biopharmaceuticals Revenue, 2016-2027
6.7.2 Turkey Biopharmaceuticals Market Size, 2016-2027
6.7.3 Israel Biopharmaceuticals Market Size, 2016-2027
6.7.4 Saudi Arabia Biopharmaceuticals Market Size, 2016-2027
6.7.5 UAE Biopharmaceuticals Market Size, 2016-2027
7 Players Profiles
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Biopharmaceuticals Major Product Offerings
7.1.4 Roche Biopharmaceuticals Revenue in Global (2016-2021)
7.1.5 Roche Key News
7.2 Amgen
7.2.1 Amgen Corporate Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Biopharmaceuticals Major Product Offerings
7.2.4 Amgen Biopharmaceuticals Revenue in Global (2016-2021)
7.2.5 Amgen Key News
7.3 AbbVie
7.3.1 AbbVie Corporate Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Biopharmaceuticals Major Product Offerings
7.3.4 AbbVie Biopharmaceuticals Revenue in Global (2016-2021)
7.3.5 AbbVie Key News
7.4 Sanofi-Aventis
7.4.1 Sanofi-Aventis Corporate Summary
7.4.2 Sanofi-Aventis Business Overview
7.4.3 Sanofi-Aventis Biopharmaceuticals Major Product Offerings
7.4.4 Sanofi-Aventis Biopharmaceuticals Revenue in Global (2016-2021)
7.4.5 Sanofi-Aventis Key News
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporate Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Biopharmaceuticals Major Product Offerings
7.5.4 Johnson & Johnson Biopharmaceuticals Revenue in Global (2016-2021)
7.5.5 Johnson & Johnson Key News
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Biopharmaceuticals Major Product Offerings
7.6.4 Pfizer Biopharmaceuticals Revenue in Global (2016-2021)
7.6.5 Pfizer Key News
7.7 Novo Nordisk
7.7.1 Novo Nordisk Corporate Summary
7.7.2 Novo Nordisk Business Overview
7.7.3 Novo Nordisk Biopharmaceuticals Major Product Offerings
7.4.4 Novo Nordisk Biopharmaceuticals Revenue in Global (2016-2021)
7.7.5 Novo Nordisk Key News
7.8 Eli Lilly
7.8.1 Eli Lilly Corporate Summary
7.8.2 Eli Lilly Business Overview
7.8.3 Eli Lilly Biopharmaceuticals Major Product Offerings
7.8.4 Eli Lilly Biopharmaceuticals Revenue in Global (2016-2021)
7.8.5 Eli Lilly Key News
7.9 Novartis
7.9.1 Novartis Corporate Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Biopharmaceuticals Major Product Offerings
7.9.4 Novartis Biopharmaceuticals Revenue in Global (2016-2021)
7.9.5 Novartis Key News
7.10 Merck
7.10.1 Merck Corporate Summary
7.10.2 Merck Business Overview
7.10.3 Merck Biopharmaceuticals Major Product Offerings
7.10.4 Merck Biopharmaceuticals Revenue in Global (2016-2021)
7.10.5 Merck Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com